Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations

Melanoma, a skin cancer associated with high mortality rates, is highly radio- and chemotherapy resistant but can also be very immunogenic. These circumstances have led to a recent surge in research into therapies aiming to boost anti-tumor immune responses in cancer patients. Among these immunother...

Celý popis

Podrobná bibliografia

Vydané v:	Frontiers in oncology Ročník 8; s. 86
Hlavní autori:	Seidel, Judith A., Otsuka, Atsushi, Kabashima, Kenji
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland Frontiers Media S.A 28.03.2018
Predmet:	biomarkers cancer immune checkpoint inhibitors immunotherapy melanoma Oncology side effects mode of action biomarkers immunotherapy melanoma side effects cancer immune checkpoint inhibitors
ISSN:	2234-943X, 2234-943X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!